NCNA · NuCana plc American Depositary Share
View on chartInsiders & Stakes
No transactions found.
Transaction History
No transactions found.
No transactions found.
No transactions found.
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
NuCana Secures European Patent for NUC-7738
NuCana announced that the European Patent Office has granted a composition-of-matter patent for its drug candidate NUC-7738. This milestone strengthens the company's intellectual property position in Europe. The stock is currently trading near its 52-week low, reflecting the broader uncertainty often seen in early-stage biotech firms.
NuCana Secures European Patent for NUC-7738. NuCana announced that the European Patent Office has granted a composition-of-matter patent for its drug candidate NUC-7738. This milestone strengthens the company's intellectual property position in Europe. The stock is currently trading near its 52-week low, reflecting the broader uncertainty often seen in early-stage biotech firms.